New directions in the coordination chemistry of 99mTc: A reflection on technetium core structures and a strategy for new chelate design

Nuclear Medicine and Biology

Volumn 32, Issue 1, 2005, Pages 1-20

  Banerjee, Sangeeta Ray ^a   Maresca, Kevin P ^d   Francesconi, Lynn ^b   Valliant, John ^c   Babich, John W ^d   Zubieta, Jon ^a  

^a SYRACUSE UNIVERSITY   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d A Subsidiary of Lantheus Holdings   (United States)

Author keywords

99mTc imaging agents; HYNIC; MAG3; Single amino acid chelates (SAAC); Tc(CO)3 1+ core

Indexed keywords

AMINO ACID DERIVATIVE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CHELATE; FIBRINOGEN RECEPTOR ANTAGONIST; HYDRAZINE DERIVATIVE; METAL ION; N OXYSUCCINIMIDYLHYDRAZINONICOTINAMIDE; NICOTINAMIDE; RADIOACTIVE MATERIAL; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

CHEMICAL STRUCTURE; MACROMOLECULE; METHODOLOGY; OXIDATION; REVIEW; SOLID; SOLID PHASE SYNTHESIS;

CHELATING AGENTS; DRUG DESIGN; ISOTOPE LABELING; ORGANOTECHNETIUM COMPOUNDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 13244251095     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.09.001     Document Type: Review

References (186)

1. R. Alberto Technetium CCC II 5 2004 127 270
2. S.S. Jurisson, and J.D. Lydon Potential technetium small molecule radiopharmaceuticals Chem. Rev. 99 1999 2205 2218
3. 99mTc-labeled small peptides as diagnostics radiopharmaceuticals Chem. Rev. 99 1999 2235 2268
4. 99mTc labeling of highly potent small peptides Bioconjug. Chem. 8 1997 621 636
5. J.R. Dilworth, and S.J. Parrott The biomedical chemistry of technetium and rhenium Chem. Soc. Rev. 27 1998 43 55
6. R.K. Hom, and J.A. Katzenellenbogen Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results Nucl. Med. Biol. 24 1997 485 498
7. W.C. Eckelman Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems Eur. J. Nucl. Med. 22 1995 249 263 [and references therein]
8. K. Schwochau Technetium radiopharmaceuticals: fundamentals, synthesis, structure and development Angew. Chem. Int. Ed. Engl. 33 1994 2258 2267
9. S. Jurisson, D. Berning, W. Jia, and D. Ma Coordination compounds in nuclear medicine Chem. Rev. 93 1993 1137 1156
10. M. Nicolini U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine vol. 6 2002 Servizi Grafici Editoriali pnc Padova (Italy)
11. M. Nicolini G. Bandoli U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine vol. 5 1999 SGE Editoriali Padova
12. M. Nicolini G. Bandoli U. Mazzi Technetium and rhenium in chemistry and nuclear medicine 1990 Raven Press New York
13. J. Steigman, and W. Eckelman The chemistry of technetium in medicine 1992 National Academy Press Washington (DC)
14. T.C. Pinkerton, C.P. Desilets, D.J. Hoch, M.V. Mikelsons, and G.M. Wilson Bioinorganic activity of technetium radiopharmaceuticals J. Chem. Educ. 62 1985 965 973
15. E. Deutsch, K. Libson, S. Jurisson, and L.F. Lindoy Technetium chemistry and technetium radiopharmaceuticals Prog. Inorg. Chem. 30 1983 75 139
16. Int. J. Appl. Radiat. Isot. 33 10 1983 793 951 [special issue on Tc]
17. E. Deutsch, W. Bushong, K.A. Glavan, R.C. Elder, V.J. Sodd, and K.L. Scholz Heart imaging with cationic complexes of technetium Science 214 1981 85 86
18. E. Deutsch, and K. Libson Recent advances in technetium chemistry: bridging inorganic chemistry and nuclear medicine Comment. Inorg. Chem. 3 1984 83 103
19. E. Deutsch J. Nicolini H.N. Wagner Technetium in chemistry and nuclear medicine 1983 Cortina International Verona Italy
20. 99mTc Coord. Chem. Rev. 78 1987 253 331
21. S. Liu, D.S. Edwards, A.R. Harris, S.J. Hemingway, and J.F. Barrett Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine: synthesis and characterization Inorg. Chem. 38 1999 1326 1335
22. G. Bandoli, A. Dolmella, M. Porchea, F. Refosco, and F. Tisato Structural overview of technetium compounds Coord. Chem. Rev. 214 2001 43 90
23. R.M. Pearlstein, C.J.L. Lock, R. Faggiani, C.E. Costello, C.H. Zeng, and A.G. Jones Synthesis and characterization of technetium(V) complexes with amine, alcoholate, and chloride ligands Inorg. Chem. 27 1988 2409 2413 [and references therein]
24. +, where R is an alkyl or benzyl group and DMPE is 1,2-bis(dimethylphosphino)ethane Inorg. Chem. 28 1989 1174 1179
25. T. Konno, M.J. Heeg, and E. Deutsch Thiolato-technetium complexes. 3: Synthesis and x-ray structural studies on the geometrical isomers cis- and trans-bis(p-chlorobenzenethiolato)bis(1,2-bis(dimethylphosphino)ethane) technetium(III) Inorg. Chem. 28 1989 1694 1700 [and references therein]
26. 99mTc-MIBI scintimammography in suspected breast cancer J. Nucl. Med. 40 1999 296 301 [and references therein]
27. J.P. Leonard, D.P. Novotnik, and R.D. Nierinckx Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT - a comparison with iodine-123 HIPDM J. Nucl. Med. 27 1986 1819 1823
28. A. Hoepping, J. Babich, J. Zubieta, K.M. Johnson, S. Machill, and A.P. Kozikowski Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine Bioorg. Med. Chem. Lett. 9 1999 3211 3214
29. P.D. Acton, P.T. Meyer, P.D. Mozley, K. Plossl, and H.F. Kung Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography Eur. J. Nucl. Med. 27 2000 1714 1718
30. 99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers J. Nucl. Med. 41 2000 584 589
31. 99mTc]N-benzyl-3,4-di-(N-2- mercaptoethyl)-amino-pyrrolidines (P-BAT) Nucl. Med. Biol. 26 1999 217 224
32. 99mTc]TRODAT-1 in nonhuman primates Eur. J. Nucl. Med. 26 1999 342 347
33. 99mTc]TRODAT-1 as dopamine transporter imaging agents J. Med. Chem. 41 1998 428 436
34. H.F. Kung, H.-J. Kim, M.P. Kung, S.K. Miegalla, K. Plössl, and H.-K. Lee Imaging of dopamine transporters in humans with technetium-99m TRODAT-1 Eur. J. Nucl. Med. 23 1996 1527 1530
35. D.L. Kukis, M. Li, and C.F. Meares Selectivity of antibody-chelate conjugates for binding copper in the presence of competing metals Inorg. Chem. 32 1993 3981 3982
36. E. Volkert, and E.A. Deutsch Bone-seeking radiopharmaceuticals in cancer therapy Adv. Met. Med. 1 1993 115 153
37. R.C. Walovitch, T.C. Hill, S.T. Garrity, E.H. Cheesman, B.A. Burgess, and D.H. O'Leary Characterization of technetium-99m-L, L-ECD for brain perfusion imaging. Part 1: Pharmacology of technetium-99m ECD in nonhuman primates J. Nucl. Med. 30 1989 1892 1901
38. U. Scheffel, H.W. Goldfarb, S.Z. Lever, R.L. Gungor, H.D. Burns, and H.N. Wagner Jr. Comparison of technetium-99m aminoalkyl diaminodithiol (DADT) analogs as potential brain blood flow imaging agents J. Nucl. Med. 29 1988 73 82
39. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function Ann. Nucl. Med. 15 2001 179 190
40. G. Johnson, K.N. Nguyen, Z.G. Liu, and R.D. Okada Technetium 99m-HL-91: a potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion J. Nucl. Cardiol. 5 1998 285 294
41. S. Liu, and D.S. Edwards Fundamentals of receptor-based diagnostic metalloradio-pharmaceuticals Top. Curr. Chem. 222 2002 259 278
42. D.R. Vera, K.A. Krohn, R.C. Stadelnik, and P.O. Scheibe Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes Radiology 151 1984 191 196
43. M.B. Skaddan, F.R. Wüst, S. Jonson, R. Syhre, M.J. Welch, and H. Spies Radiochemical synthesis and tissue distribution of Tc-99m-labeled substituted estradiol complexes Nucl. Med. Biol. 27 2000 269 278
44. M.J. Welch, J.B. Downer, and J.A. Katzenellenbogen Steroid hormone receptors as targets for diagnostic imaging Dev. Nucl. Med., Curr. Dir. Radiopharm. Res. Dev. 30 1996 137 156
45. R.K. Hom, D.Y. Chi, and J.A. Katzenellenbogen Heterodimeric bis(amino thiol) complexes of oxorhenium(v) that mimic the structure of steroid hormones. Synthesis and stereochemical issues J. Org. Chem. 61 1996 2624 2631
46. D.Y. Chi, J.P.O. O'Neil, C.J. Anderson, M.J. Welch, and J.A. Katzenellenbogen Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones J. Med. Chem. 37 1994 928 937 [and references therein]
47. J.P. O'Neil, S.R. Wilson, and J.A. Katzenellenbogen Preparation and structural characterization of monoamine-monoamide bis(thiol) oxo complexes of technetium(V) and rhenium(V) Inorg. Chem. 33 1994 319 323
48. D.Y. Chi, and J.A. Katzenellenbogen Selective formation of heterodimeric bis-bidentate aminothiol-oxometal complexes of rhenium(V) J. Am. Chem. Soc. 115 1993 7045 7046
49. 188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting Nucl. Med. Biol. 26 1999 687 693
50. M. Giblin, S.S. Jurisson, and T.P. Quinn Synthesis and characterization of rhenium-complexed alpha-melanotropin analogs Bioconjug. Chem. 8 1997 347 353
51. M. Giblin, N. Wang, T.J. Hoffmann, S.S. Jurisson, and T.P. Quinn Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination Proc. Natl. Acad. Sci. U. S. A. 95 1998 12814 12818
52. J.-P. Chen, C. Zhen, Y. Miao, S.S. Jurisson, and T.P. Quinn α-Melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting Cancer 94 2002 1196 1201
53. W.M. Yeh, D.G. Sherman, and C.F. Meares A new route to "bifunctional" chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid Anal. Biochem. 100 1979 152 159
54. C.F. Meares, and T.G. Wensel Metal chelates as probes of biological systems Acc. Chem. Res. 17 1984 202 209
55. M.W. Brechbiel, O.A. Gansow, R.W. Atcher, J. Schlom, J. Esteban, and D.E. Simpson Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies Inorg. Chem. 25 1986 2772 2781 [and references therein]
56. D.J. Hnatowich, A. Mardirossen, M. Ruscowski, M. Fargarasi, F. Virji, and P. Winnard Jr. Directly and indirectly technetium-99m-labeled antibodies - a comparison of in vitro and animal in vivo properties Nucl. Med. Chem. 34 1993 109 119
57. P.J. Blower, and S. Prakash The chemistry of rhenium in nuclear medicine Perspect. Bioinorg. Chem. 4 1999 91 143
58. M. Papadopoulos, B. Nock, T. Maina, I. Pirmettis, C. Raptopoulou, and A. Tasiopoulos Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluation J. Biol. Inorg. Chem. 6 2001 159 165
59. 99mTc-labelled agents Nucl. Med. Biol. 22 1996 325 328 [and references therein]
60. T.N. Rao, D. Adhikesavalu, A. Camerman, and A.R. Fritzberg Technetium (V) and rhenium (V) complexes of 2,3-bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological properties J. Am. Chem. Soc. 112 1990 5798 5804
61. S. Meegalla, K. Plössl, M.-P. Kung, S. Chumpradit, D.A. Stevenson, and S.A. Kushner Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents J. Med. Chem. 40 1997 9 14 [and references therein]
62. 3S ligands Bioconjug. Chem. 8 1997 407 415
63. A. Pollak, D.G. Roe, C.M. Pollack, L.F. Lu, and J.R. Thornback A convenient method of preparing high specific activity technetium complexes using thiol-containing chelators adsorbed on gold J. Am. Chem. Soc. 121 1999 11593 11594
64. 2N′S peptidic chelator: evidence of interconversion between the syn and anti conformations Inorg. Chem. 36 1997 5799 5808
65. 99mTc]chelator-peptide conjugates Bioconjug. Chem. 7 1996 196 202
66. 3S-adipate) Bioconjug. Chem. 9 1998 108 117
67. 99mTc labeling J. Nucl. Med. Biol. 28 2001 703 708 [and references therein]
68. G.H. Van Domselaar, S.M. Okarvi, M. Fanta, M.R. Suresh, and D.S. Wishart Synthesis and 99m Tc-labeling of bz-MAG3-triprolinyl-peptides, their radiochemical evaluation and in vitro receptor-binding J. Labelled Compd. Radiopharm. 43 2000 1193 1204
69. A. Goodbody, and A. Pollak Peptide-chelator conjugates for diagnostic imaging PCT Int. Appl. 1995 [22 pp.]
70. 99mTc-labeled chemotactic peptides: analogs with reduced netropenia Nucl. Med. Commun. 17 1996 132 139
71. J. Lister-James, L.C. Knight, A.H. Mauer, L.R. Bush, B.R. Moyer, and R.T. Dean Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide J. Nucl. Med. 37 1996 775 781
72. D.A. Pearson, J. Lister-James, W.J. McBride, D.M. Wilson, L.J. Martel, and E.R. Civitello Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies J. Med. Chem. 39 1996 1361 1371
73. D.S. Wishart Tools for protein technologies C. Ratledge B. Kristiansen 2nd ed. Biotechnology 5b 2001 325 344
74. S. Ben-Haim, D. Kahn, G.J. Weiner, M.T. Madsen, A.D. Waxman, and C.M. Williams The safety and pharmacokinetics in adult subjects of an intravenously administer 99mTc-labeled 17 amino acid peptide (CYT-379) Nucl. Med. Biol. 21 1994 131 142
75. L.G. Luyt, and D.H. Hunter Technetium-99m labeling of tamoxifen and lysine derivatives using an N2S2 bifunctional chelator: single isomer radiopharmaceuticals 217th ACS National Meeting Anaheim, Calif., March 21-25 Book of abstracts 1999 [NUCL-184]
76. 2N′S peptidic chelator: evidence of interconversion between the syn and anti conformations Inorg. Chem. 36 1997 5799 5808
77. 2 ligand having carboxyl groups anti to the oxo group Inorg. Chem. 39 2000 5731 5747 [and references therein]
78. F. Tisato, F. Refosco, F. Ossola, C. Bolzati, and G. Bandoli Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores Transit. Met. Chem. 22 1997 606 607
79. 2-ligands Inorg. Chim. Acta 330 2002 17 24
80. C. Bolzati, F. Tisato, F. Refosco, G. Bandoli, and A. Domella Uncommon anionic dioxorhenium(V) and neutral monooxorhenium(V) mixed-ligand complexes containing heterofunctionalized phosphine ligands: syntheses and structural characterization Inorg. Chem. 35 1996 6221 6229
81. 99gTc(V) and Re(V) complexes with water soluble tetraaza diamido dipyridino ligands: single crystal x-ray structural investigations of mono- and dinuclear complexes Inorg. Chem. 42 2003 2960 2967
82. M. Papadopoulos, I. Pirmettis, C. Tsoukalas, B. Nock, T. Maina, and C.P. Raptopoulou Study on the formation of mixed ligand oxorhenium and oxotechnetium complexes (SNS/S combination) Inorg. Chim. Acta 295 1999 1 8
83. S. Seifert, A. Gupta, R. Syhre, H. Spies, and B. Johannsen Ligand-exchange reaction of labile "3+1" 99mTc(V) complexes with SH group-containing proteins Appl. Radiat. Isot. 54 2001 637 644 [and references therein]
84. R. Syhre, S. Seifert, H. Spies, A. Gupta, and B. Johannsen Stability versus reactivity of "3+1" mixed-ligand technetium-99m complexes in vitro and in vivo Eur. J. Nucl. Med. 25 1998 793 796
85. B. Nock, T. Maina, F. Tisato, M. Papadopoulos, C.P. Raptopoulou, and A. Terzis Synthesis and characterization of six-coordinate "3+2" mixed-ligand oxorhenium complexes with the o-diphenylphosphinophenolato ligand and tridentate coligands of different N and S donor atom combinations Inorg. Chem. 39 2000 2178 2184
86. J.A. Arterburn, K.A. Hall, I.M. Fogarty, D.M. Goreham, J.C. Bryan, and K.C. Ott Synthesis, characterization and mechanistic aspects of the formation of biologically relevant rhenium imido complexes 210th ACS National Meeting Chicago, IL August 20-24 Book of abstracts Pt. 1 1995 [INOR-451]
87. 5=(2- (ditolylphosphino)propanethiolato] Inorg. Chem. 38 1999 4473 4479
88. C. Bolzati, A. Boschi, L. Uccelli, F. Tisato, F. Refosco, and A. Cagnolini Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+(PXP=diphosphine ligand). A novel tool for the selective labeling of small molecules J. Am. Chem. Soc. 124 2002 11468 11479 [and references therein]
89. 3) Polyhedron 7 1988 171 185
90. A.R. Cowley, J.R. Dilworth, and P.S. Donnelly A mono-diazenide complex from perrhenate: toward a new core for rhenium radiopharmaceuticals Inorg. Chem. 42 2003 929 931
91. 2] Polyhedron 6 1987 1577 1585
92. 2], a complex with a hydrazido(1-) ligand with a large angular distortion Inorg. Chem. 24 1985 2594 2595
93. 4N)] Inorg. Chim. Acta 252 1996 421 426
94. M. Hirsch-Kuchma, T. Nicholson, A. Davison, and A.G. Jones Group 7 "organohydrazide" chemistry: classification of ligand type based on crystal structural data J. Chem. Soc., Dalton Trans. 1997 3189 3192
95. yNNR)} core and their relationship to radiolabeled organohydrazine-derivatized chemotactic peptides with diagnostic applications Inorg. Chem. 37 1998 2701 2716 [and references therein]
96. 3- ion Inorg. Chem. 19 1980 1105 1110
97. R. Waibei, R. Alberto, J. Willude, R. Finnern, R. Schibli, and A. Stichelberger Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex Nat. Biotechnol. 17 1999 897 901
98. 99mTc-aquaion labels peptide to an unprecedented high specific activity J. Nucl. Med. 40 1999 1913 1917
99. 99mTc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules Bioconjug. Chem. 11 2000 345 351
100. + Chem.-Eur. J. 9 2003 2053 2061
101. 3] Transit. Met. Chem. 22 1997 597 601
102. - in aqueous solution and its reaction with a bifunctional ligand J. Am. Chem. Soc. 120 1998 7987 7988
103. 99mTc J. Am. Chem. Soc. 121 1999 6076 6077
104. + retains biological activity in vitro Nucl. Med. Biol. 28 2001 243 250
105. + and synthesis of tailor-made bifunctional ligand systems Bioconjug. Chem. 13 2002 750 756
106. + J. Am. Chem. Soc. 123 2001 3135 3136
107. S.M. Okawi, P. Adriaens, and A.M. Verbruggen Synthesis, radiolabeling characteristics and biological evaluation of the derivatives of mercaptoacetyltriglycine Radiochim. Acta 90 2002 423 429
108. 3-conjugated morpholino oligomers Bioconjug. Chem. 13 2002 893 897 [and references therein]
109. 3 as a hippuran replacement J. Nucl. Med. 27 1986 111 116
110. 186Re-labeling of monoclonal antibodies Cancer 73 3, Suppl. 1994 769 773
111. 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results J. Nucl. Med. 42 2001 154 161
112. 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies J. Nucl. Med. 42 2001 1722 1727
113. E. Wong, S. Bennett, B. Lawrence, T. Fauconnier, L.F.L. Lu, and R.A. Bell Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study Inorg. Chem. 40 2001 5695 5700
114. J. Blum, H. Handmaker, and N.A. Rinne Technetium labeled small peptide radiopharmaceuticals in the identification of lung cancer Curr. Pharm. Des. 8 2002 1827 1836
115. D.A. Pearson, J. Lister-James, W.J. McBride, D.M. Wilson, L.J. Martel, and E.R. Civitello Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies J. Med. Chem. 39 1996 1361 1371
116. M.A. De Rosch, D.A. Pearson, J.E. Cyr, R. Manchanda, J.V. Rutkowski, and C.A. Nelson Somatostatin imaging receptor agents: characterization of Tc 99m depreotide 217th ACS National Meeting, Anaheim, Calif., March 21-25 Book of Abstracts 1999 [NUCL-188]
117. 3S donor ligand small peptide analogues of the N-mercaptoacetyl-glycylglycylglycine ligand in the clinically used Tc-99m renal imaging agent: evidence for unusual amide oxygen coordination by two new ligands Inorg. Chem. 41 2002 3032 3041 [and references therein]
118. 99mTc labeled to a peptide by 4 methods J. Nucl. Med. 42 2001 1870 1877
119. D.A. Schwartz, M.J. Abrams, M.M. Hauser, F.E. Gaul, S.K. Larsen, and D. Rauh Preparation of hydrazino-modified proteins and their use of the synthesis of technetium-99m-protein conjugates Bioconjug. Chem. 2 1991 333 336
120. J.W. Babich, H. Solomon, M.C. Pike, D. Kroon, W. Graham, M.J. Abrams, R.G. Tompkins, R.H. Rubin, and A.J. Fischman Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection J. Nucl. Med 34 1993 1964 1970
121. J.W. Babich, and A.J. Fischman Effect of "co-ligand" on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides Nucl. Med. Biol. 22 1995 25 30
122. A.J. Fischman, D. Rauh, H. Solomon, J.W. Babich, R.G. Tompkins, and D. Kroon In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates J. Nucl. Med. 34 1993 2130 2134
123. 111In IgG Nucl. Med. Biol. 22 1995 643 648
124. J.W. Babich, W. Graham, S.A. Barrow, S.C. Dragotaker, R.H. Tompkins, and R.H. Rubin Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit J. Nucl. Med. 34 1993 2176 2181
125. J.W. Babich, R.G. Tompkins, W. Graham, S.A. Barrow, and A.J. Fischman Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism J. Nucl. Med. 38 1997 1316 1322
126. 3 integrin for tumor imaging Bioconjug. Chem. 13 2002 561 570
127. 4 receptor antagonist useful for imaging infection and inflammation Bioconjug. Chem. 13 2002 881 886
128. J. Szebeni, L. Baranji, S. Savaj, J. Milosevits, R. Bunger, and P. Laverman Role of compliment activation in hypersensitivity reactions to doxil and HYNIC PEG liposomes: experimental and clinical studies J. Liposome Res. 12 2002 165 172
129. R.A. Claessens, E.B. Koenders, W.J.G. Oyen, and F.H. Corstens Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonictinamido and iminothiolato immunoglobulin Eur. J. Nucl. Med. 23 1996 1536 1539
130. C.J. van der Laken, O.C. Boerman, W.J.G. Oyen, M.P.P. van der Ven, J.W.M. van der Meer, and F.H.M. Corstens Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection Eur. J. Nucl. Med. 23 1996 1531 1535
131. D.S. Edwards, S. Liu, M.C. Ziegler, A.R. Harris, A.C. Crocker, and S.J. Hemingway RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging Bioconjug. Chem. 10 1999 884 891
132. D.S. Edwards, and S. Liu Tc-99m radiopharmaceuticals based on a ternary ligand system comprised of a water soluble phosphine Phosphorus Sulfur 144-146 1999 493 496
133. E.M.Th. Dams, W.J.G. Oyen, O.C. Boerman, G. Storm, P. Laverman, and E.B. Koenders Technetium-99m labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG J. Nucl. Med. 39 1998 2172 2178
134. 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-containing heterocycles as coligands Bioconjug. Chem. 9 1998 583 595
135. D.S. Edwards, S. Liu, J.A. Barrett, A.R. Harris, R.J. Looby, and M.C. Ziegler New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc Bioconjug. Chem. 8 1997 146 154
136. 99mTc-labeling of a hydrazinonicotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors Bioconjug. Chem. 12 2001 624 629
137. 3-octreotide: first results in patients and comparison with
138. 111In- octreotide J. Nucl. Med. 41 2000 1114 1119
139. 1-octreotide Eur. J. Nucl. Med. 27 2000 628 637
140. 111In-labelled octreotide derivatives Eur. J. Nucl. Med. 27 2000 1318 1325
141. 99mTc] complex Liebigs Ann. Chem. 9 1996 1463 1469
142. W.E.P. Greenland, K. Howland, J. Hardy, I. Fogelman, and P.J. Blower Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-ε- (Hynic-Boc-)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin J. Med. Chem. 46 2003 1751 1757
143. T.E. Hugli Chemotaxis Curr. Opin. Immunol. 2 1989 19 27
144. R.B. Bourret, and A.M. Stock Molecular information processing: lessons from bacterial chemotaxis J. Biol. Chem. 277 2002 9625 9628
145. T.F. Deuel, R.M. Senior, D. Chang, G.L. Griffin, R.C. Hendrickson, and E.T. Kaiser Platelet factor 4 is chemotactic for neutrophils and monocytes Proc. Natl. Acad. Sci. U. S. A. 78 1981 4584 4587
146. H.J. Showell, R.J. Freer, S.H. Zigmond, E. Schiffman, S. Aswanikumar, and B. Corcoran The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils J. Exp. Med. 143 1976 1154 1169
147. E. Schiffmann, B.A. Corcoran, S.M. Wahl, E. Schiffmann, B.A. Corcoran, and S.M. Wahl N-formylmethionyl peptides as chemoattractants for leucocytes Proc. Natl. Acad. Sci. U. S. A. 72 1975 1059 1062
148. L.T. Williams, R. Synderman, M.C. Pike, and R.J. Lefkowitz Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes Proc. Natl. Acad. Sci. U. S. A. 74 1977 1204 1208
149. R. Snyderman, and M.W. Verghese Leukocyte activation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism Rev. Infect. Dis. 9 1987 S562 S569
150. M.P. Fletcher, B.G. Seligman, and J.I. Gallin Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity J. Immunol. 128 1982 941 948
151. J. Niedel, S. Wilkinson, and P. Cuatrecasas Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils J. Biol. Chem. 254 1979 10700 10706
152. J. Niedel, J. Davis, and P. Cuatrecasas Covalent affinity labeling of the formyl peptide chemotactic receptor J. Biol. Chem. 255 1980 7063 7066
153. 2): a new coligand for Tc-99m labeling of hydrazino-nicotinamide (HYNIC) peptides [in preparation].
154. H.J.J. Rennen, J.E. van Eerd, W.J.G. Oyen, F.H.M. Corstens, D.S. Edwards, and O.C. Boerman Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection Bioconjug. Chem. 13 2002 370 377
155. 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes Bioconjug. Chem. 13 2002 491 501
156. 99mTc-labelled peptides Q. J. Nucl. Med. 46 2002 195 205
157. D.S. Edwards, and S. Liu Tc-99m radiopharmaceuticals based on a ternary ligand system comprised of a water soluble phosphine Phosphorus Sulfur 144-146 1999 493 496
158. +]G Bioconjug. Chem. 15 2004 128 136
159. M. Bodansky Principles of peptide synthesis 1984 Springer Verlag Berlin
160. M. Bodansky, and A. Bodansky The practice of peptide synthesis 1984 Spring-Verlag Berlin
161. S. Aimoto Contemporary methods for peptide and protein synthesis Curr. Org. Chem. 5 2001 45 87 [and references therein]
162. H. Gausepohl, and C. Behn Automated peptide synthesis, cleavage and purification Innovation Perspect. Solid Phase Synth. Collect. Papers, Int. Symp., 3rd 1994 175 182 [and references therein]
163. E. Atherton, and R.C. Sheppard Solid phase peptide synthesis 1989 IRC Press Oxford
164. G.C. Barrett, and D.T. Elmore Amino acids and peptides 1998 Cambridge Univ. Press Cambridge
165. J.A. Bravo, A. Gibson, K. Laughran, and M. Bradley Solid-phase synthesis of oxo(mercaptoacetylglycylglycylglycine)rhenate(V) Chem. Commun. 2001 837 838
166. P.S. Rao, V.R. Pallela, D. Vassileva-Belnikolovska, D. Jungkind, and M.L. Thakur A receptor-specific peptide for imaging infection and inflammation Nucl. Med. Commun. 21 2000 1063 1070
167. T.J. Hoffman, T.P. Quinn, and W.A. Volkert Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells Nucl. Med. Biol. 28 2001 527 539
168. R.T. Dean, S. Buttram, W. McBride, J. Lister-James, and E.R. Civitello Preparation of technetium-99m labeled peptides for imaging, U.S. 1999 [Cont.-in-part of U.S. Ser. No. 851,074] [14 pp.]
169. R.T. Dean, S. Buttram, W. McBride, J. Lister-James, and E.R. Civitello Technetium-99m-labeled peptides for imaging PCT Int. Appl. 1995 [42 pp.] [WO 9533498]
170. 3} core complexes with bifunctional ligands constructed from amino acids and analogues M. Nicolini U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine vol. 6 2002 Servizi Grafici Editoriali pnc Padova (Italy) 227
171. M.P. Smith, D. Keith, K.P. Maresca, N.S. Kula, R.J. Baldessarini, and F.I. Tarazi Novel ligands for cerebral monoamine transporters: rhenium and technetium oxo-complexes of 4-arylpiperidines M. Nicolini U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine vol. 6 2002 Servizi Grafici Editoriali pnc Padova (Italy) 183
172. +1 cores M. Nicolini U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine vol. 6 2002 Servizi Grafici Editoriali pnc Padova (Italy) 111
173. +1 cores M. Nicolini U. Mazzi Technetium, rhenium and other metals in chemistry and nuclear medicine vol. 6 2002 Servizi Grafici Editoriali pnc Padova (Italy) 155
174. 2)] Inorg. Chem. 41 2002 6417 6425
175. 3} core complexes with bifunctional single amino acid chelates Inorg. Chem. 41 2002 5795 5802
176. S. Mundwiler, L. Candreia, P. Haefliger, K. Ortner, and R. Alberto Preparation of no-carrier-added technetium-99m complexes via metal-assisted cleavage from a solid phase Bioconjug. Chem. 15 2004 195 202
177. S. Mundwiler, L. Candreia, and R. Alberto Selective release of technetium complexes from a solid phase due to C-N bond cleavage upon metal coordination Chimia 57 2003 193 195
178. 2O substitution Inorg. Chem. 42 2003 3516 3526
179. R. La Bella, E. Garcia-Garayoa, M. Baehler, P. Blaeuenstein, R. Schibli, and P. Conrath A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent Bioconjug. Chem. 13 2002 599 604
180. 2Me}]Br Inorg. Chem. Commun. 7 2004 481 484
181. M.K. Levadala, S.R. Banerjee, K.P. Maresca, J.W. Babich, and J. Zubieta Direct reductive alkylation of amino acids: synthesis of bifunctional chelates for nuclear imaging Synthesis 2004 1159 1166
182. 2Br] Inorg. Chem. Commun. 7 2004 1023
183. R. Schibli, and P.A. Schubiger Current use and future potential of organometallic radiopharmaceuticals Eur. J. Med. Mol. Imaging 29 2002 1529 1542
184. F. Le Bideau, M. Salmain, S. Top, and G. Jaouen New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives Chem.-Eur. J. 7 2001 2289 2294
185. M. Salmain, M. Gunn, A. Gorfti, S. Top, and G. Jaouen Labeling of proteins by organometallic complexes of rhenium(I). Synthesis and biological activity of the conjugates Bioconjug. Chem. 4 1993 425 433
186. G. Jaouen, A. Vessieres, S. Top, and M. Salmain Bioorganometallic chemistry in the study of receptors and in analysis. I. Study of the estrogen receptor Actual. Chim. 1996 9 15